Omega-3 beneficial in non-alcoholic fatty liver disease

Omega-3 beneficial in non-alcoholic fatty liver disease

Monday 15th of May 2017

Share

A new meta-analysis has shown that supplementation with omega-3 polyunsaturated fatty acids, especially docosahexaenoic acid, has a favourable effect in the treatment of non-alcoholic fatty liver disease.

Non-alcoholic fatty liver disease (NAFLD) - a leading cause of chronic liver disease - encompasses a wide spectrum of conditions, ranging from steatosis to non-alcoholic steatohepatitis, fibrosis, cirrhosis and hepatocellular carcinoma.  According to available evidence the prevalence of NAFLD is 10 percent in children and affecting up to as high as 30 percent adults in Western countries.

To continue reading this article, please Log In or Register for access.